Pharma etf india. The scheme primarily invests in pharma stocks.
Pharma etf india -listed India ETFs and every India ETF has one issuer. Get the latest Nippon India Nifty Pharma ETF (PHARMABEES) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Nippon India Nifty Pharma ETF: Learn the investment objectives & performance of the fund. Get access to 9500+ Indian & International ETFs, invest in pre-defined ETF Packs using industry-first tools and be a part of our exclusive ETF investment community. H Get latest NAV, Returns, SIP Returns, Performance, Ranks, Dividends, Portfolio, CRISIL Rank, Expert Recommendations, and Comparison with gold, stock,ULIP etc. 69%. 74 Glenmark Pharmaceuticals Limited 1. 18 Cadila Healthcare Limited 2. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. 79 Divi's Laboratories Limited* 17. 18% Gain from 52W Low 2. The fund was launched in Jul 6, 2021. ETFs can invest in different industry sector. 20 Biocon Limited* 3. granules india ltd. 21 Natco Pharma Limited 1. The NAV of the fund as on Jan 31, 2025 is ₹21. 13% in Small Cap stocks. 24. sun pharmaceutical industries ltd. 68 Pfizer Limited 1. dr. Jan 29, 2025 · Nippon India Nifty Pharma ETF - Get information on the latest NAV, mutual fund yearly returns, SIP returns, mutual fund performance, and mutual fund scheme objectives at ICICI Direct Stocks Groww provides information and tools for investing in Nippon India Nifty Pharma ETF, a fund that tracks the performance of the NIFTY Pharma Index. View all ETFs Get latest NAV, Returns, SIP Returns, Performance, Ranks, Dividends, Portfolio, CRISIL Rank, Expert Recommendations, and Comparison with gold, stock,ULIP etc. Nippon India Nifty Pharma ETF; Fund / Benchmark(Value of ₹10,000 invested) 1 Year 3 Year 5 Year Since Inception; Amount in ₹ Returns (%) Amount in ₹ Returns (%) Amount in ₹ Returns (%) Amount in ₹ Returns (%) NAV as on December 31, 2024: ₹23. Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Jul 31, 2021 · Pharmaceuticals Sun Pharmaceutical Industries Limited* 22. The Nippon India Nifty Pharma ETF (G) has an asset allocation of 0% in equity and equity equivalents and 0% in debt securities. Nippon India ETF Bank BeES (BANKBEES) The Nippon India ETF NIFTY Bank BeES tracks Nifty Bank TRI, offering exposure to the banking sector. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee. Dec 2, 2024 · Nippon India Nifty PHARMA ETF. Exchange Traded Funds. Check detailed stocks and debt portfolio holding, changes in portfolio, list of stocks bought/sold, risk analysis of debt holding 20 hours ago · Nippon Pharma ETF (PHARMABEES) Companies - Get complete details of list of stocks with sector bifurcation, sector weightage, live share price, share price change and more. 96% investment in domestic equities of which 55. 85. Feb 27, 2024 · Nippon India Nifty Pharma ETF 2 year return (CAGR): 22% Corpus: Rs 578 crore Also see: Chasing multibaggers: Micro-cap stocks that Flexicap MFs added. 41 crore as of July 31. 76 Abbott India Limited 2. b. 80 Alkem Laboratories Limited* 4. 60 Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. - Nippon India Mutual Fund - Nippon India Nifty Pharma ETF (NSE: PHARMABEES) stock price quote with financials, statistics, dividends, charts and more. 84% is in Mid Cap stocks, 2. 18% upper at Rs 22. VIP or Value averaging 6 days ago · A mutual fund scheme that tracks the NIFTY Pharma Index and invests in 20 pharma stocks. 23. Get detailed information about the Nippon India Nifty Pharma ETF. 79 Glenmark Pharmaceuticals Limited 1. Get latest NAV, returns & detailed information on Pharma Mutual Funds. In the past week the ETF fell -6. 82 Natco Pharma Limited 1. This fund has been in existence for 3 years, 5 months and 29 days, having been launched on 06-Jul-21. Top 25% Risk Adjusted Performance Parameters: Nippon India Nifty Pharma ETF has two risk-adjusted performance parameters of the fund that are in the top 25% of the category. Now Jan 3, 2025 · An exchange-traded fund (ETF) is the basket of securities that tracks an underlying index and can be traded on an exchange, just like a stock. See share price, fund returns, portfolio holdings, expense ratio, and more. 21. See the best pharmaceutical ETFs of 2023 ranked by performance and get a market outlook for big pharma stocks in 2024. Its Sep 30, 2021 · Aurobindo Pharma Limited* 4. 4 days ago · Interactive stock price chart for Nippon Life India Asset Management Ltd. 29 Pfizer Limited 1. b. Nippon India Nifty Auto ETF. While returns are lower, they are more stable, making it suitable for conservative investors. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Nippon India Nifty Pharma ETF Growth Regular Plan - Analysis enables you to decide, if it is a right Fund for you based on the Fund Performance, Portfolio, Rolling Returns, Latest NAV ₹22. The Nippon India NIFTY Pharma ETF Growth Plan is an exchange-traded fund that closely tracks the NIFTY Pharma Index, comprising the top pharma stocks in India like Cipla, Divis Lab and Lupin among others. The metric calculations are based on U. , Johnson & Johnson, and Get Nippon India Nifty Pharma ETF share prices, along with historic price charts for NSE/BSE. is trading 0. 10 Cadila Healthcare Limited* 4. reddy's laboratories ltd. 33% is in Large Cap stocks, 24. the Nifty Pharma Index before expenses, subject to tracking errors. Aurobindo Pharma Limited* 2. 73%) Overview; ETFs Nifty Pharma - ETF LIST - ETF SHARE PRICE, AUM, TRACKING ERROR, COMPARISON. Visit Groww. 1 day ago · Nippon India Nifty Pharma ETF Live Share Price Today, Share Analysis and Chart. Comparing various metrics against peers can give valuable insights on how the ETF is performing and ETF's growth as compared to other ETF's that are tracking the same index. Nippon India Nifty Pharma ETF was launched on July 2, 2021. 43 Learn about Nippon India Nifty Pharma ETF with our data and independent analysis including NAV, star rating, portfolio, detailed portfolio, performance, risk and rating, factsheet Live PHARMABEES Stock / Share Price - Get live NSE/ BSE Share Price of PHARMABEES, latest research reports, key ratios, fiancials and stock price history of Nippon India NIFTY Pharma ETF Growth Plan only at HDFC Securities. Jan 3, 2025 · Performance charts for Nippon India Nifty Pharma ETF (NIFPHETF - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. 30 IPCA Laboratories Limited 3. 27 Aurobindo Pharma Limited* 7. sanofi india ltd. 28 Alkem Laboratories Limited* 3. You can view this in the overview section. Get latest NAV, Returns, SIP Returns, Performance, Ranks, Dividends, Portfolio, CRISIL Rank, Expert Recommendations, and Comparison with gold, stock,ULIP etc. Discover the key highlights and important insights into Nippon India Nifty Nippon India Nifty Pharma ETF is a Sector - Healthcare mutual fund schemes offered by Nippon India Mutual Fund. The ETF has assets under management (AUM) at ₹706. com 5 days ago · Get the latest information and complete track record of Nippon India Nifty Pharma ETF schemes, returns, latest NAV and ratings from independent mutual fund research house. 2 days ago • Economic Times ETF issuers who have ETFs with exposure to Pharmaceutical are ranked on certain investment-related metrics, including estimated revenue, 3-month fund flows, 3-month return, AUM, average ETF expenses and average dividend yields. Nippon India Silver ETF. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Bond/Liquid ETFs, Inverse ETFs, Leveraged ETFs, Synthetic ETFs. 16% on an intraday basis. 91 Pfizer Limited 1. Track Nippon India Nifty Pharma ETF Chart History including Candlestick & Periodic charts with different indicators. Invest in Nippon India Nifty Pharma ETF at 5paisa today! Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. Reddy's Laboratories Limited* 15. mankind pharma ltd. 48 IPCA Laboratories Limited 3. 22 Natco Pharma Limited 1. India's Largest Regional Retail Option Traders Summit. 64 Zydus Lifesciences Limited 2. Jan 27, 2025 · Get the latest Nippon Life India Asset Management Ltd. It can contain a different type of investments like stocks, commodities, bonds or the mixture of these investment types. Jan 21, 2025 · Nippon India Nifty Pharma ETF - Get information on the latest NAV, mutual fund yearly returns, SIP returns, mutual fund performance, and mutual fund scheme objectives at ICICI Direct Latest Nippon India Nifty Pharma ETF (NETFPHARMA:NSI:INR) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 21. Now ICICI Prudential Mutual Fund - ICICI Prudential Nifty Healthcare ETF Share or Stock Price - Get Live BSE/NSE Price Details, Financial Results, Charts, Performance with Todays Low or High, 52 Week Low or High, Holdings and more. 60 Torrent Pharmaceuticals Limited 3. glenmark pharmaceuticals ltd. natco pharma ltd. 47 Torrent Pharmaceuticals Limited 3. 81 Abbott India Limited 2. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Find the latest Nippon India Nifty Pharma ETF (NETFPHARMA. 54% in Small Cap stocks. The debut dates for all of the aforementioned Pharma ETFs are in 2021. 1000 and thereafter. 63 Torrent Pharmaceuticals Limited* 3. TATA India Pharma & Healthcare Fund. biocon ltd. Disclaimer. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Dec 7, 2024 · The best ETFs in India, based on expense ratios, include BHARAT Bond ETF FOF – April 2032, BHARAT Bond ETF FOF – April 2033, Axis Nifty AAA Bond Plus SDL Apr 2026 50:50 ETF FoF, Mirae Asset Nifty200 Alpha 30 ETF FoF and Mirae Asset S&P 500 Top 50 ETF FoF. - Nippon India Mutual Fund - Nippon India Nifty Pharma ETF (NSE: PHARMABEES) with real-time updates, full price history, technical analysis and more. Nifty Healthcare ETFs invest in leading healthcare and pharmaceutical companies driving India's medical sector. % 1m; 5m; 15m; 30m; 1hr; Exchange Traded Funds 1 day ago · Note: a. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Nippon India Nifty Pharma ETF; Fund / Benchmark(Value of ₹10,000 invested) 1 Year 3 Year 5 Year Since Inception; Amount in ₹ Returns (%) Amount in ₹ Returns (%) Amount in ₹ Returns (%) Amount in ₹ Returns (%) NAV as on December 31, 2024: ₹23. • To create a market through substantial education & awareness – As the Indian ETF market is at a nascent stage, NAM India is committed towards the Nifty Pharma Index before expenses, subject to tracking errors. divi's laboratories ltd. 17 Torrent Pharmaceuticals Limited* 4. View the current NIPT stock price chart, historical data, premarket price, dividend returns and more. See current NAV, trailing and rolling returns, asset allocation, top holdings, sector exposure and more. 20 hours ago · The Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. 4. ETFs are available to invest in stocks, commodities, bonds, foreign market etc. As of 2023, Deloitte has valued the Nippon India NIFTY Pharma ETF Growth Plan Share Price - Get live NSE/BSE updates on Nippon India NIFTY Pharma ETF Growth Plan stock price including performance, fundamentals, market cap, shareholding, technical analysis, news & company profile at Kotak Securities! Sep 20, 2022 · The pharmaceutical exchange-traded funds (ETFs) with the best one-year trailing total returns are PPH, IHE, and PJP. Nippon India Nifty PHARMA ETF has been trading in the price range of 22. Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which will be listed on NSE and will be investing in Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. ETF has been down -7. 67 as compared to its last closing price. NS stock on Yahoo Finance. 13. 46 Glenmark Pharmaceuticals Limited 1. (BOTS) is a prestigious options trading event organized by Traders Gurukul. 40 Gland Pharma Limited* 4. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein are on the basis of 1 Year CAGR returns NETFPHARMA Portfolio - Learn more about the Nippon India Nifty Pharma ETF investment portfolio including asset allocation, stock style, stock holdings and more. 50 Glenmark Pharmaceuticals Limited 1. in and Start Investing in ICICI Prudential Mutual Fund - ICICI Pruden Jun 28, 2021 · This Nippon India Nifty Pharma ETF is currently available as a NFO. 38 GlaxoSmithKline Pharmaceuticals Limited 1. TOP EXCHANGE TRADED FUND. 6 days ago · The SBI 10 YEAR GILT ETF tracks 10-year Government of India bonds, offering exposure to government securities. The Nippon India Nifty Pharma ETF is an open-ended mutual fund offered by Nippon India Mutual Fund. The portfolio of the fund shall comprise stocks that constitute the Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. 54 Biocon Limited* 3. Feedback. 7200 (-2. India’s first platform dedicated to Exchange Traded Funds (ETFs). • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Nippon India Nifty Pharma ETF Share Price Chart - View today’s PHARMABEES Stock Price Chart for BSE and NSE at Groww. gland pharma ltd. View all ETFs Get detailed Portfolio analysis for Nippon India Nifty Pharma ETF. One-time Jan 27, 2025 · Nippon India Nifty Pharma ETF - Growth Fund Details. Its risk level is Very High. Home; Portfolio; Mutual Funds. Find the best sectoral pharma funds with expert reviews, detailed insights, and performance analysis. 4 days ago · ICICI Prudential Nifty Healthcare ETF is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. 1 day ago · An exchange-traded fund (ETF) is the basket of securities that tracks an underlying index and can be traded on an exchange, just like a stock. Click to know more & invest in Nippon India Nifty Pharma ETF now! 4 days ago · Nippon India Nifty Pharma ETF Invest Online . 51. Minimum application for the NFO is Rs. 61 Cipla Limited* 12. 43 IPCA Laboratories Limited 3. The Scheme does not assure or Jan 28, 2025 · Nippon India Nifty Pharma ETF: Get latest Nav, Price Trend, Performance, Returns, Rankings & Peer Comparison. laurus labs ltd. Dhuraivel Gunasekaran. Given the heightened focus on the healthcare and pharmaceutical industry in light of the Covid-19 pandemic, there is a high probability that much more pharma ETFs will be launched in India. H Bond/Liquid ETFs, Inverse ETFs, Leveraged ETFs, Synthetic ETFs. One-time 5 days ago · Nippon India Nifty Pharma ETF is an Equity - Sector - Healthcare fund. 23 Gland Pharma Limited 2. Nov 5, 2024 · Total assets under management: US$624. 75 Lupin Limited* 7. Click here to invest in mutual funds online today! See full list on getmoneyrich. One-time 1 day ago · Exchange Traded Funds (ETF's) are one of the most important and valuable products created for individual investors in recent years. 06 Dr. 68 6 days ago · Nippon Pharma ETF (PHARMABEES) Share Price Today - Get complete details of PHARMABEES price on NSE/BSE, live chart, sector wise weightage, list of stocks, and more. 03 Biocon Limited* 4. 50 Zydus Lifesciences Limited 2. NIPPON INDIA NIFTY PHARMA ETF Sector : ETF | Industry : ETF aurobindo pharma ltd. Dec 27, 2024 · Index Funds/ETFs : Index Funds/ETFs : The fund has 100% investment in domestic equities of which 49. See the latest details on the top-performing pharma ETFs. Stock 2 days ago · ETF issuers who have ETFs with exposure to India are ranked on certain investment-related metrics, including estimated revenue, 3-month fund flows, 3-month return, AUM, average ETF expenses and average dividend yields. 19. Very High . The top holdings of these ETFs are Mckesson Corp. 97 Abbott India Limited 2. Nippon India Nifty Pharma ETF, NETFPHARMA:NSI:INR summary - FT. The 5 Best Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio 1. What are peers and why compare against them? An ETF's peers are ETFs which have the same underlying index. Himanshu Mange has been the fund manager of Nippon India Nifty Aug 19, 2022 · For the Indian stock market, pharma ETFs are new. 8601: Nippon India Nifty Pharma ETF: Inception Date: Jul 2, 2021: Nippon India Nifty Pharma 22. Calculate SIP, VIP Returns. 4 days ago · Check Nippon India Nifty Pharma ETF's latest information like performance, NAV, returns, expense ratio & more. Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores . 10%. 5M NSE Volume Nippon India Nifty Pharma ETF is currently trading down -2. The net asset value (NAV) of an ETF is based on the current prices of the stocks/assets in the fund and an actual accounting of the total cash in the fund at the time of calculation. 78% is in Large Cap stocks, 18. 32 (1. 64 Alkem Laboratories Limited* 3. 85 Biocon Limited* 3. Index Funds/ETFs : Index Funds/ETFs : The fund has 99. Nippon India Nifty Pharma ETF. Jul 31, 2022 · Aurobindo Pharma Limited* 3. Pay ₹0 Brokerage on Equity Delivery, Mutual Funds, ETFs & IPO. 7,048,513. lupin ltd. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Jan 29, 2025 · Nippon India Nifty Pharma ETF shareholding pattern – Promoter holding and pledges, FII, DII, and Mutual Fund holding changes for the latest quarter. Investment Objective - The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. pharma stocks mixed; New fiscal consolidation Market Wrap: Sensex surges 759 points, Nifty tops 24,100 boosted by Reliance, Adani, pharma stocks. 09 Pfizer Limited 1. 20 Equity Less Than 1% of Corpus 0. 13 0. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Sep 12, 2023 · In this article, we discuss the 12 best pharma ETFs. Jan 9, 2025 · Get latest Nippon India NIFTY Pharma ETF Growth Plan share price & performance trends with Today's Low or High, 52 Week Low or High. Funds Home NEW; Medalist Rating NEW; Factsheets NEW; Fund News NEW; Screen Funds Nippon India Nifty Pharma ETF Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding Analysis, and Peers. Find detailed report in terms of 52 week high/low, charts, news, scheme details, peer scheme comparison, dividend history, return calculator and more. ICICI Prudential Pharma Healthcare and Diagnostics (P. 64 Abbott India Limited 2. View daily, weekly or monthly format back to when Nippon India Nifty Pharma ETF stock was issued. The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. 90 Gland Pharma Limited* 3. 0. S. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio An exchange-traded fund (ETF) is the basket of securities that tracks an underlying index and can be traded on an exchange, just like a stock. 29, Expense Ratio, Fund Review, and more. The scheme primarily invests in pharma stocks. Now Discover historical prices for NETFPHARMA. Learn more about ETF's- Exchange Traded Funds visit NSE India. 16 Cadila Healthcare Limited 2. 8601: Nippon India Nifty Pharma ETF: Inception Date: Jul 2, 2021: Nippon India Nifty Pharma 4 days ago · Note: a. com Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein are on the basis of 1 Year CAGR returns Feb 18, 2023 · Nippon India NIFTY Pharma ETF Growth Plan Historical Data, Stock Analysis, Buy/Sell Signal, Targets, Charts, Latest News, Technical Analysis, Fundamental Analysis, Live NSE/BSE Updates, Financial data and Ratios. 09. -listed Pharmaceutical ETFs and every Pharmaceutical ETF has one issuer. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio 6 days ago · If the demand for pharmaceutical products suddenly skyrockets, like in the case of an epidemic or pandemic, then the stocks of the pharma companies also rise which in turn takes the index value up and if supply is more than the demand, then the opposite scenario takes place as stock of medicines and other pharma products piles up leading to losses. Motilal Oswal NASDAQ 100 ETF | Nippon India Multi Cap Fund Dec 31, 2021 · Aurobindo Pharma Limited* 4. 34 Equity Less Than 1% of Corpus 2. 52%. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio The net asset value (NAV) of an ETF is based on the current prices of the stocks/assets in the fund and an actual accounting of the total cash in the fund at the time of calculation. Mr. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Nippon India Mutual Fund - Nippon India Nifty Pharma ETF Share Price Today, Live NSE Stock Price: Get the latest Nippon India Mutual Fund - Nippon India Nifty Pharma ETF news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account Oct 9, 2024 · Nippon India Nifty Pharma ETF PHARMABEES. Scripbox provides a unique feature through which you can compare the performance of Nippon India Nifty Pharma ETF (G) with another fund in a similar category. 88 & 22. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved. In total, the iShares US Pharmaceuticals ETF has 40 holdings Get the latest Nippon India Nifty Pharma ETF (PHARMABEES) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. With ET Money online process start investing in best Pharma sector funds. 73% is in Mid Cap stocks, 2. NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Stay updated with real-time market information & start investing in Nippon India NIFTY Pharma ETF Growth Plan with m. 5. For Nippon India Nifty Pharma ETF, we have evaluated three risk-adjusted performance parameters. 98 Created with Highcharts 9. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. Being passively managed, it replicates the portfolio of its chosen benchmark index. 51 Gland Pharma Limited 1. Index Funds/ETFs : The fund has 99. chemicals & pharmaceuticals ltd. j. This way you can make a well-informed investment decision. Know about corporate actions, dividend trends, bonus, splits and other announcements for Nippon India Nifty Pharma ETF 4 days ago · Nippon India Nifty PHARMA ETF Key Metrics: Explore the key metrics and financial ratios of Nippon India Nifty PHARMA ETF. • Nippon India Nifty Pharma ETF is a low cost product in terms of total expense ratio Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. 22. 31 million Created on May 5, 2006, this iShares ETF tracks some of the top US pharma companies. Himanshu Mange manages 32 open-ended schemes of Nippon India Mutual Fund. Scheme Features Nippon India Nifty Pharma ETF Page 4 Nippon Life India Asset Management Limited (NAM India) is one of the largest asset managers with more than 26 years of experience in managing wealth of investors with a robust distribution network in India and a global reach through its various subsidiaries. Here are the best Nifty Healthcare ETFs to buy in 2025. • To create a market through substantial education & awareness – As the Indian ETF market is at a nascent stage, NAM India is committed towards. cipla ltd. NSE; BSE; card; Nippon India ETF Gold BeES ₹68. Nippon India Nifty Pharma ETF Invest Online . 27 Sanofi India Limited 1. 45% in the past year. 96 Start Invest Online in Equity - Sectoral Fund - Pharma & Health Care in India, Compare all Equity - Sectoral Fund - Pharma & Health Care mutual funds & get regular updates on performance, portfolio holdings & free advisory with FundsIndia. 2. 47 %) 30. 49% in the past quarter and rose 19. ipca laboratories ltd. Unrated. . 09 Historical data for the Nippon India Nifty Pharma ETF (NIPT) as well as the closing price, open, high, low, change and %change. Positioning – Nippon India Nifty Pharma ETF • Nippon India Nifty Pharma ETF is an Exchange Traded Fund (ETF) which is listed on NSE and investing in stocks of Nifty Pharma Index in the same proportion as the underlying Index. 54 Natco Pharma Limited 1. 63 Biocon Limited 2.